33288-71-0 (2-[4-氨基磺酰-苯基]-乙基-5-甲基吡嗪甲酰胺,5-methyl-N-[2-(4-sulfamoylphenyl)ethyl]pyrazine-2-carboxamide)

2-[4-氨基磺酰-苯基]-乙基-5-甲基吡嗪甲酰胺;格列吡嗪相关化合物 A;格列吡嗪杂质A;格列吡嗪杂质A(EP) 标准品;格列吡嗪杂质I;N-[2-[4-(胺基磺酰基)苯基]乙基]-5-甲基-吡嗪酰胺;

5-Methyl-N-(4-sulfamoylphenethyl)pyrazine-2-carboxamide;4-[β-(5-Methylpyrazinyl-2-carboxamido)ethyl]benzene Sulfonamide;2-[4-Aminosulfonyl-phenyl]-ethyl-5-methylpyrazinecarboxamide;4-(B-(5-METHYLPYRAZINE-2-CARBOXY-AMIDO)ETHYL)BENZENE SULFONAMIDE;4-(β-(5-Methylpyrazine-2-carboxy-amido)ethyl)benzene Sulfonamide;5-Methyl-N-(4-sulfamoylphenethyl)-pyrazine-2-carboxamide;4-[2-(5-Methylpyrazine-2-carboxamido)ethyl]benzenesulfonamide;5-methyl-N-[2-(4-sulfamoylphenyl)ethyl]pyrazine-2-carboxamide;Glipizide Related Compound A;N-{2-[4-(Aminosulfonyl)phenyl]ethyl}-5-methyl-2-pyrazinecarboxamide;N-{2-[(4-aminosulfonyl)phenyl]ethyl}-5-methyl-pyrazinecarboxamide;Pyrazinecarboxamide,5-methyl-N-(p-sulfamoylphenethyl)- (8CI);Pyrazinecarboxamide, N-[2-[4-(aminosulfonyl)phenyl]ethyl]-5-methyl-(9CI);4-[2-(5-Methylpyrazinyl-2-carboxamido)ethyl]benzenesulfonamide;Pyrazinecarboxamide, N-[2-[4-(aminosulfonyl)phenyl]ethyl]-5-methyl-;IMEZLHZLIANIAS-UHFFFAOYSA-N;N-[2-[4-(aminosulfonyl)phenyl]ethyl]-5-methylpyrazine-carboxamide;4-[?-(5-Methylpyrazinyl-2-carboxamido)ethyl]benzene Sulfonamide;A821712;4-[b-(5-Methylpyrazinyl-2-carboxamido)ethyl]benzene Sulfonamide;CS-0215413;BCP13823;SCHEMBL7826309;4-(2-(5-METHYLPYRAZINE-2-CARBOXAMIDO)ETHYL)BENZENESULFONAMIDE;GLIPIZIDE IMPURITY A [EP IMPURITY];4-(5-(3-methylbenzyl)-4,5,6,7-tetrahydrooxazolo[4,5-c]pyridin-2-yl)benzoic acid;5-Methyl-N-(2-(4-sulfamoylphenyl)ethyl)pyrazine-2-carboxamide;5-methyl-n-[2-(4-sulphamoylphenyl)ethyl]pyrazine-2-carboxamide;EN300-245286;EBQ9973HL9;Glipizide impurity A;4-[beta-(5-Methylpyrazinyl-2-carboxamido)ethyl]benzene Sulfonamide;4-(2-(5-METHYLPYRAZINYL-2-CARBOXAMIDO)ETHYL)BENZENESULFONAMIDE;N-(2-((4-AMINOSULFONYL)PHENYL)ETHYL)-5-METHYL-PYRAZINECARBOXAMIDE;PYRAZINECARBOXAMIDE, N-(2-(4-(AMINOSULFONYL)PHENYL)ETHYL)-5-METHYL-;Z30858000;33288-71-0;DTXSID00186914;GLIPIZIDE EP IMPURITY A (USP RC A);{2-[4-Aminosulphonyl-phenyl]-ethyl}-5-methylpyrazinecarboxamide;Q27277096;FT-0672110;Glipizide Imp. A (EP); Glipizide USP Related Compound A; Glipizide USP RC A; 5-Methyl-N-[2-(4-sulphamoylphenyl)ethyl]pyrazine-2-carboxamide; Glipizide Related Compound A; Glipizide Impurity A;NS00029451;AC-15563;PYRAZINECARBOXAMIDE, 5-METHYL-N-(P-SULFAMOYLPHENETHYL)-;AKOS007992962;UNII-EBQ9973HL9;Glipizide Imp. A (EP): 5-Methyl-N-[2-(4-sulphamoylphenyl)ethyl]pyrazine-2-carboxamide;DB-068799;N-[2-[4-(Aminosulfonyl)phenyl]ethyl]-5-methyl-2-pyrazinecarboxamide;N-[2-[4-(aminosulfonyl)phenyl]ethyl]-5-methylpyrazine carboxamide;

MFCD08458207

IMEZLHZLIANIAS-UHFFFAOYSA-N

1S/C14H16N4O3S/c1-10-8-18-13(9-17-10)14(19)16-7-6-11-2-4-12(5-3-11)22(15,20)21/h2-5,8-9H,6-7H2,1H3,(H,16,19)(H2,15,20,21)

S(C1C=CC(=CC=1)CCNC(C1C=NC(C)=CN=1)=O)(N)(=O)=O

2935009090